Orchestra BioMed Holdings (OBIO) Shares Outstanding (Weighted Average) (2022 - 2025)
Orchestra BioMed Holdings (OBIO) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $52.2 million as the latest value for Q3 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 43.34% to $52.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $52.2 million, a 43.34% increase, with the full-year FY2024 number at $36.8 million, up 10.82% from a year prior.
- Shares Outstanding (Weighted Average) was $52.2 million for Q3 2025 at Orchestra BioMed Holdings, up from $38.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $52.2 million in Q3 2025 to a low of $9.2 million in Q1 2022.
- A 4-year average of $30.7 million and a median of $33.2 million in 2023 define the central range for Shares Outstanding (Weighted Average).
- Peak YoY movement for Shares Outstanding (Weighted Average): soared 199.66% in 2023, then increased 6.87% in 2025.
- Orchestra BioMed Holdings' Shares Outstanding (Weighted Average) stood at $15.0 million in 2022, then skyrocketed by 121.67% to $33.2 million in 2023, then increased by 10.82% to $36.8 million in 2024, then skyrocketed by 41.73% to $52.2 million in 2025.
- Per Business Quant, the three most recent readings for OBIO's Shares Outstanding (Weighted Average) are $52.2 million (Q3 2025), $38.3 million (Q2 2025), and $38.2 million (Q1 2025).